Reaction

Aortic Dissection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,115 reports · 67 co-occurring drugs

As of the last recalculation, Aortic Dissection appears in 4,115 FAERS reports alongside 67 co-occurring drug terms. The strongest observed disproportionality signal is ROMOSOZUMAB-AQQG (PRR 14.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Romosozumab-Aqqg	39	14.7	14.7
Dabigatran Etexilate Mesylate	132	9.5	9.5
Dabigatran Etexilate	121	8.1	8.1
Alteplase	21	7.1	7.1
Lenvatinib	43	6.7	6.7
Sunitinib Malate	49	6.4	6.4
Sorafenib	26	6.4	6.4
Labetalol	15	5.7	5.7
Bevacizumab	133	5.6	5.6
Prasugrel Hydrochloride	11	5.5	5.5
Tolvaptan	14	4.9	4.9
Granisetron Hydrochloride	10	4.9	4.9
Granisetron	10	4.8	4.8
Losartan Potassium And Hydrochlorothiazide	11	4.8	4.8
Axitinib	18	4.7	4.7
Moxifloxacin	13	4.7	4.7
Febuxostat Tablets 40 Mg	9	4.5	4.5
Febuxostat Tablets 80 Mg	9	4.5	4.5
Pitavastatin Calcium	9	4.5	4.5
Heparin Sodium	12	4.4	4.4
Levofloxacin	52	4.4	4.4
Levofloxacin In 5% Dextrose	52	4.4	4.4
Magnesium Oxide	34	4.1	4.1
Nifedipine	36	3.9	3.9
Moxifloxacin Hydrochloride	15	3.8	3.8
Ciprofloxacin Hydrochloride And Hydrocortisone	15	3.7	3.7
Regorafenib	8	3.5	3.5
Leucovorin Calcium	13	3.4	3.4
Testosterone	15	3.3	3.3
Oseltamivir	5	3.2	3.2
Capecitabine	56	3.1	3.1
Clopidogrel Bisulfate	61	3.0	3.0
Everolimus Tablets	10	3.0	3.0
Apalutamide	7	3.0	3.0
Bendamustine Hydrochloride	7	3.0	3.0
Febuxostat	9	2.7	2.7
Fluorouracil	40	2.6	2.6
Abiraterone	7	2.6	2.6
Fluorouracil Cream, 0.5%	39	2.6	2.6
Panitumumab	8	2.6	2.6
Paclitaxel (Aibumin-Bound)	40	2.5	2.5
Oxaliplatin	36	2.5	2.5
Amphetamine	4	2.4	2.4
Pazopanib Hydrochloride	13	2.4	2.4
Methoxy Polyethylene Glycol-Epoetin Beta	5	2.3	2.3
Rasagiline Mesylate	5	2.3	2.3
Testosterone Cypionate	4	2.3	2.3
Gefitinib	4	2.2	2.2
Paclitaxel	41	2.1	2.1
Cabozantinib	19	2.0	2.0
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	3	1.9	1.9
Pembrolizumab	38	1.8	1.8
Diclofenac Potassium, Film Coated	3	1.8	1.8
Diclofenac Potassium Tablets	3	1.8	1.8
Sofosbuvir	7	1.8	1.8
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	11	1.8	1.8
Abiraterone Acetate	14	1.7	1.7
Pemetrexed	7	1.7	1.7
Encorafenib	3	1.5	1.5
Trifluridine And Tipiracil	3	1.4	1.4
Glecaprevir And Pibrentasvir	3	1.4	1.4
Enzalutamide	16	1.4	1.4
Atezolizumab	10	1.3	1.3
Durvalumab	5	1.2	1.2
Ledipasvir And Sofosbuvir	4	1.1	1.1
Sarilumab	5	1.0	1.0
Cinacalcet Hydrochloride	5	0.5	0.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.